Ashwagandha for Anxiety: KSM-66 vs Sensoril, Cortisol Evidence, and the 8-Week Window

Ashwagandha sits in an interesting position in the supplement world: it has more quality human RCTs behind it than most adaptogens, but the word "adaptogen" itself means almost nothing on a label. Whether the bottle you are looking at contains an extract that resembles what was used in the trials depends entirely on the extract standard listed, and most labels do not make this clear enough.

This article is structured around the practical decisions involved: which extract to choose, what the best evidence actually shows, when to expect changes, and what the honest caveats are.

Ashwagandha has real bioactive compounds and interacts with hormone systems. If you have a thyroid condition, are pregnant, take immunosuppressants, or have an autoimmune condition, please speak with your healthcare provider before starting it. Rare cases of liver injury associated with certain ashwagandha products have been reported. This is wellness information, not medical advice or a treatment recommendation for any anxiety disorder.

Which form of ashwagandha is in the research?

Withania somnifera is the botanical name. The active compounds most studied are withanolides, a class of steroidal lactones found primarily in the root. The concentration and type of withanolides varies enormously between raw powder (typically 0.1 to 0.5% withanolides) and standardized extracts (5 to 10%).

Two patented extract standards show up in most quality clinical trials:

If the label on your product does not say KSM-66 or Sensoril (or another named extract), you are buying unstandardized ashwagandha powder. The withanolide content may be anywhere from trace to high depending on the batch and supplier. This is not necessarily unsafe, but you cannot compare your dose to the clinical literature meaningfully.

There are other standardized extracts (Shoden, which standardizes to 35% withanolides, has some emerging trial data, but fewer studies than KSM-66 at the time of writing).

What do the cortisol RCTs actually show?

Two trials stand out for quality and are worth understanding in detail:

Both trials have limitations: they are relatively small (60 to 64 participants), conducted in India where stress profiles and dietary context differ from, say, a North American population, and the manufacturers of KSM-66 were not involved in these specific trials but the extract is commercially available, which creates a potential commercial ecosystem around positive results. These are real limitations, not reasons to dismiss the studies, but they are worth naming.

A 2021 systematic review by Pratte et al. (referenced below) and a 2021 meta-analysis by Priyanka et al. in Medicine pooled multiple ashwagandha trials and found consistent directional evidence for reductions in stress, anxiety, and cortisol, with the caveat that most trials were small and used different outcome measures.

How does ashwagandha affect cortisol and why does that matter for anxiety?

Cortisol is the primary glucocorticoid released by the adrenal glands as part of the HPA axis stress response. In chronic psychological stress, morning cortisol is often elevated and the normal daily cortisol curve (high in the morning, low in the evening) becomes flatter and dysregulated.

Ashwagandha's proposed mechanism is at the level of the HPA axis. Withanolides appear to modulate the sensitivity of the axis to stress signals, reducing the cortisol output for a given stressor. There is also evidence from animal studies that withanolides inhibit the enzyme CYP11B1, which is involved in cortisol synthesis, though whether this is the primary mechanism in humans is not established.

There are also GABAergic effects: some withanolides appear to bind GABA-A receptors, similar to how benzodiazepines act but much less potently. This provides a possible direct anxiolytic mechanism distinct from the cortisol pathway.

The significance of a 27.9% reduction in serum cortisol (as seen in Chandrasekhar 2012) is context-dependent. If your cortisol is elevated due to chronic stress, reducing it toward the normal range is likely to feel better. If your cortisol is already in a normal range and your anxiety is primarily driven by cognitive or situational factors, the effect may be smaller.

The 8-week window: why response takes time

Both major trials measured their primary outcomes at 8 weeks. This is not arbitrary. The HPA axis adapts slowly, and steroid hormone regulation changes take weeks to months to stabilize.

Some people report noticing reduced physical tension or a calmer baseline within 2 to 3 weeks of daily use. This could reflect early GABA-mediated effects, or it could reflect expectation. The meaningful cortisol changes in the trials were measured at 8 weeks.

If you start ashwagandha and assess it after 2 weeks because you don't feel different, you are likely assessing too early. The evidence suggests setting an 8-week minimum window, with consistent daily dosing.

What dose and how should you take it?

Based on the trials above:

• KSM-66: 300 mg twice daily (600 mg total), taken morning and evening. This is the dose from both Chandrasekhar 2012 and Langade 2019.
• Sensoril: 125 to 250 mg daily, usually once per day, because its higher withanolide concentration means less compound is needed.
• Unstandardized powder: Cannot be meaningfully compared to the research doses.

Taking ashwagandha with food reduces the chance of gastrointestinal discomfort, which is the most common mild side effect reported in trials (and which occurred at similar rates in placebo groups in most trials, suggesting it is not always supplement-related).

Risks, interactions, and who should be cautious

Ashwagandha is generally well-tolerated in the trial populations studied. But it is a bioactive compound that affects hormone systems, and a few cautions are important:

• Thyroid conditions. Ashwagandha appears to increase T3 and T4 thyroid hormone levels in some studies. People with hyperthyroidism or on thyroid medication should monitor and discuss with their physician.
• Pregnancy. Traditionally contraindicated; ashwagandha has been used as an abortifacient in large doses historically. Avoid during pregnancy.
• Autoimmune conditions. Some withanolides have immunostimulatory effects. People with lupus, rheumatoid arthritis, or similar conditions, or on immunosuppressants, should consult a physician.
• Liver safety. A small number of case reports in the medical literature have described liver injury temporally associated with ashwagandha products. The cause-effect relationship is not established and may involve adulterated or non-standard products, but it is worth flagging. Stop use and seek medical attention if you develop jaundice, dark urine, or unusual abdominal symptoms.
• Sedatives and CNS drugs. Given the potential GABAergic activity, additive sedative effects with benzodiazepines or alcohol are theoretically possible, though not well-studied in humans.

This article is wellness information only and does not constitute medical advice. Ashwagandha is not a treatment for anxiety disorders. If anxiety is significantly affecting your life, please work with a healthcare provider. Do not stop or reduce any prescribed medication because you are taking ashwagandha.